Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks
Panagiotis Asteris, Eleni Gavriilaki, Tasoula Touloumenidou, Evaggelia‐Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, Alexandros Pouleres, Vassiliki Karali, Minas E. Lemonis, Anna Mamou, Athanasia D. Skentou, Apostolia Papalexandri, Christos Varelas, Fani Chatzopoulou, Maria Chatzidimitriou, Dimitrios Chatzidimitriou, Anastasia Veleni, Evdoxia Rapti, Ioannis Kioumis, Evangelos Kaimakamis, Milly Bitzani, Dimitrios T. Boumpas, Argyris Tsantes, Damianos Sotiropoulos, Αναστασία Παπαδοπούλου, Ioannis Kalantzis, Lydia A. Vallianatou, Danial Jahed Armaghani, Liborio Cavaleri, Amir Gandomi, Mohsen Hajihassani, Mahdi Hasanipanah, Mohammadreza Koopialipoor, Paulo B. Lourénço, Pijush Samui, Jian Zhou, Ioanna Sakellari, Serena Valsami, Marianna Politou, Styliani Kokoris, Αchilles Anagnostopoulos (2022). Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks. Journal of Cellular and Molecular Medicine, 26(5), pp. 1445-1455, DOI: 10.1111/jcmm.17098.
Article404 days agoGenetic justification of severe COVID-19 using a rigorous algorithm
Eleni Gavriilaki, Panagiotis Asteris, Tasoula Touloumenidou, Evaggelia-Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, Vassiliki Karali, Apostolia Papalexandri, Christos Varelas, Fani Chatzopoulou, Maria Chatzidimitriou, Dimitrios Chatzidimitriou, Anastasia Veleni, Savvas Grigoriadis, Evdoxia Rapti, Diamantis Chloros, Ioannis Kioumis, Evangelos Kaimakamis, Milly Bitzani, Dimitrios Boumpas, Argyris Tsantes, Damianos Sotiropoulos, Ioanna Sakellari, Ioannis Kalantzis, Stefanos T. Parastatidis, Mohammadreza Koopialipoor, Liborio Cavaleri, Danial Jahed Armaghani, Αναστασία Παπαδοπούλου, Robert A. Brodsky, Styliani Kokoris, Αchilles Anagnostopoulos (2021). Genetic justification of severe COVID-19 using a rigorous algorithm. , 226, DOI: https://doi.org/10.1016/j.clim.2021.108726.
Article351 days agoIsatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
Philippe Moreau, Meletios A Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kihyun Kım, Gracia Martínez, Chang‐Ki Min, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, Marie‐Laure Risse, Gaëlle Asset, Sandrine Macé, Thomas G. Martin, Philippe Moreau, Meletios A Dimopoulos, Joseph Mıkhael, Kwee Yong, Marcelo Capra, Thierry Façon, Roman Hájek, Ivan Špıčka, Ross Baker, Kim Ki‐Hyun, Gracia Martínez, Min Chang‐Ki, Luděk Pour, Xavier Leleu, Albert Oriol, Youngil Koh, Kenshi Suzuki, Tom Martin, Hang Quach, Andrew Lim, Helen Crowther, Hanlon Sia, Cyrille Hulin, Mohamad Mohty, Gábor Mikala, Zsolt Nagy, Marta Reinoso Segura, Laura Rosiñol, Münci Yağcı, Mehmet Turgut, Mamta Garg, Gurdeep Parmar, Brad Augustson, Nelson Castro, Edvan de Queiroz Crusoé, Tomáš Pika, Sosana Delimpasi, Kenichi Ishizawa, Anup George, Т. С. Константинова, Javier de la Rubia, Kim Sung-Hyun, Ângelo Maiolino, Tony Reiman, Richard LeBlanc, Shigeki Ito, Junji Tanaka, А. С. Лучинин, I. V. Kryuchkova, Joaquín Martínez‐López, Jesse Shustik, Lionel Karlin, Argiris Symeonidis, Miklós Egyed, Mario Petrini, Michèle Cavo, Michihiro Uchiyama, Hilary Blacklock, Mutlu Arat, James E. Griffin, Hannah Hunter, Tonda Buck, Αchilles Anagnostopoulos, Κωνσταντίνος Κωνσταντόπουλος, Tamás Masszi, Sara Bringhen, Barbara Gamberi, Yawara Kawano, Kim Jin Seok, Hakan Özdoğu, Fahir Özkalemkaş (2021). Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. , 397(10292), DOI: https://doi.org/10.1016/s0140-6736(21)00592-4.
Article42 days agoReal‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group
Eirini Katodritou, Efstathios Kastritis, Moshe E. Gatt, Yaël C. Cohen, Irit Avivi, Anastasia Pouli, C. Lalayianni, Noa Lavi, Sosana Delimpasis, Marie‐Christine Kyrtsonis, Michalis Michael, Celia Suriu, Miri Zektser, Katrin Tzafarti, Chrysanthi Vadikoliou, Dimitris Maltezas, Panagiotis Zikos, Chezi Ganzel, Yuliana Vaxman, Ariel Aviv, Anna Christoforidou, Maria Gavriatopoulou, Adir Shaulov, Evgenia Verrou, Αριστέα-Μαρία Παπανώτα, Gabriel Fakinos, Annita Ioanna Gkioka, Vasiliki Palaska, Theodora Triantafyllou, Pavlina Konstantinidou, Αchilles Anagnostopoulos, Evangelos Terpos, Meletios A Dimopoulos (2020). Real‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group. , 95(5), DOI: https://doi.org/10.1002/ajh.25755.
Article42 days agoPomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Paul G. Richardson, Albert Oriol, Meral Beksaç, Anna Marina Liberati, Mónica Galli, Fredrik Schjesvold, Jindriska Lindsay, Katja Weisel, Darrell White, Thierry Façon, Jesús F. San Miguel, Kazutaka Sunami, Peter O’Gorman, Pieter Sonneveld, Paweł Robak, С. В. Семочкин, Steve Schey, Xin Yu, Thomas Doerr, Amine Bensmaine, Tsvetan Biyukov, Teresa Peluso, Mohamed H. Zaki, Kenneth Anderson, Meletios A Dimopoulos, Niels Abildgaard, Howard L. Adler, Fevzi Altuntaş, Olga Meltem Akay, Bipinkumar Amin, Αchilles Anagnostopoulos, Larry D. Anderson, Pekka Anttila, Carla Araujo, Carlos Arce‐Lara, Yıldız Aydın, Supratik Basu, Ramakrishna Battini, Thaddeus Beeker, Lotfi Benboubker, Dina Ben‐Yehuda, Joan Bladé, Igor Wolfgang Blau, Ralph V. Boccia, Lillian Burke, Peter D. Byeff, Nicola Cascavilla, Michèle Cavo, Andrew Chantry, Yen Charles, Arvind Chaudhry, Alessandro Corso, Mark Coyne, Felipe de Arriba, Sosana Delimpasi, P. Desjardins, Binod Dhakal, Paolo Di Bartolomeo, Francesco Di Raimondo, Jan Dürig, Monika Engelhardt, Martine Escoffre‐Barbe, Graça Esteves, Max Flogegård, Nashat Gabrail, Barbara Gamberi, Mitchell Garrison, Julie Gay, Heinz Gisslinger, Hartmut Goldschmidt, Cristina Gonçalves, Laurent Gressot, Sebastian Grosicki, Wahid T. Hanna, Patrick Hayden, Maria Manuela Henriques Bernardo, Róbert Hermann, Viran Holden, Kirsti Honkalehto, Marianne Huben, John Huffman, Hannah Hunter, Marek Hus, Madan Jagasia, Sundar Jagganath, Murali Janakiram, Ishmael Jaiyesimi, Matthew Jenner, Cristina João, Peter Johnson, Artur Jurcyszyn, Sevgi Kalayoğlu Beşışık, Suman Kambhampati, Abraham S. Kanate, Ìhsan Karadoǧan, Ali Khojasteh, Dean Kirkel, Mieczysław Komarnicki, Maria‐Theresa Krauth, Phillip Kuriakose (2019). Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial. , 20(6), DOI: https://doi.org/10.1016/s1470-2045(19)30152-4.
Article42 days ago